Overview
James Vredenburgh is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Vredenburgh is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). His top areas of expertise are Glioma, Astrocytoma, Glioblastoma, Brain Tumor, and Bone Marrow Aspiration.
His clinical research consists of co-authoring 76 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
University Of North Carolina At Chapel Hill
Natalie Grover is an Oncologist and a Hematologist in Chapel Hill, North Carolina. Dr. Grover is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). Her top areas of expertise are Marginal Zone Lymphoma (MZL), Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Grover is currently accepting new patients.
Duke Blood Cancer Center
I am convinced that caring for patients with malignant hematologic diseases requires not only up-to-date medical knowledge, but also an understanding of the individual patient's needs and circumstances. I encourage patients to take an active role in their treatment and recovery and I work with them to develop an individualized treatment plan that includes the most advanced therapies available today. My practice focuses primarily on disorders of the lymphatic system (Hodgkin and non-Hodgkin lymphoma and chronic lymphocytic leukemia). As an integral part of my clinical activities, I am dedicated to teaching young physicians at all levels of training and educating the next generation of hematologists. Dr. Stefanovic is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). Her top areas of expertise are Waldenstrom Macroglobulinemia, Diffuse Large B-Cell Lymphoma (DLBCL), Marginal Zone Lymphoma (MZL), Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration.
The Moses H Cone Memorial Hospital Operating Corporation
Mohamed Mohamed is a Hematologist and an Oncologist in Greensboro, North Carolina. Dr. Mohamed is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and EGFR Positive Lung Cancer. Dr. Mohamed is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- AstrocytomaDr. Vredenburgh isElite. Learn about Astrocytoma.
- GlioblastomaDr. Vredenburgh isElite. Learn about Glioblastoma.
- GliomaDr. Vredenburgh isElite. Learn about Glioma.
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Vredenburgh isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Brain TumorDr. Vredenburgh isDistinguished. Learn about Brain Tumor.
- Breast Cancer in MenDr. Vredenburgh isDistinguished. Learn about Breast Cancer in Men.
- EGFR Positive Lung CancerDr. Vredenburgh isDistinguished. Learn about EGFR Positive Lung Cancer.
- Gliomatosis CerebriDr. Vredenburgh isDistinguished. Learn about Gliomatosis Cerebri.
- Large-Cell Lung CarcinomaDr. Vredenburgh isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Advanced
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Vredenburgh isAdvanced. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Breast CancerDr. Vredenburgh isAdvanced. Learn about Breast Cancer.
- Embryonal Tumor with Multilayered RosettesDr. Vredenburgh isAdvanced. Learn about Embryonal Tumor with Multilayered Rosettes.
- EpendymomaDr. Vredenburgh isAdvanced. Learn about Ependymoma.
- GliosarcomaDr. Vredenburgh isAdvanced. Learn about Gliosarcoma.
- Inflammatory Breast CancerDr. Vredenburgh isAdvanced. Learn about Inflammatory Breast Cancer.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Vredenburgh isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Adult Immune ThrombocytopeniaDr. Vredenburgh isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Vredenburgh isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Vredenburgh isExperienced. Learn about Agranulocytosis.
- Anal CancerDr. Vredenburgh isExperienced. Learn about Anal Cancer.
- AngiosarcomaDr. Vredenburgh isExperienced. Learn about Angiosarcoma.
